Completed
PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.
NCT05255276
- Conditions
- Healthy Adults
- Locations
-
- Labcorp Drug Development Clinical Research Unit Dallas, Texas, United States